LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Use of Purastat, a novel haemostatic matrix based on self-assembling peptides in the prevention of nasopharyngeal adhesion formation

Photo from academic.microsoft.com

Highlights • Purastat is a novel haemostatic agent used effectively in nasal procedures in the prevention of epistaxis and adhesions.• This study describes the use of PuraStat following division of… Click to show full abstract

Highlights • Purastat is a novel haemostatic agent used effectively in nasal procedures in the prevention of epistaxis and adhesions.• This study describes the use of PuraStat following division of nasopharyngeal stenosis to reduce the risk of restenosis.• On last follow-up the patient experienced excellent resolution of symptoms with no evidence of readhesion.• The authors propose that PuraStat may be used in other surgical interventions to prevent mucosal adhesion formation.

Keywords: purastat novel; adhesion formation; novel haemostatic; use purastat

Journal Title: International Journal of Surgery Case Reports
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.